These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25696959)

  • 1. [Metabolic syndrome and melatonin].
    Rapoport SI; Molchanov AIu; Golichenkov VA; Burlakova OV; Suprunenko ES; Savchenko ES
    Klin Med (Mosk); 2013; 91(11):8-14. PubMed ID: 25696959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, its pathophysiology and the role of melatonin.
    Srinivasan V; Ohta Y; Espino J; Pariente JA; Rodriguez AB; Mohamed M; Zakaria R
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Jan; 7(1):11-25. PubMed ID: 22946959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammaging, Metabolic Syndrome and Melatonin: A Call for Treatment Studies.
    Cardinali DP; Hardeland R
    Neuroendocrinology; 2017; 104(4):382-397. PubMed ID: 27165273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?
    Nduhirabandi F; du Toit EF; Lochner A
    Acta Physiol (Oxf); 2012 Jun; 205(2):209-23. PubMed ID: 22226301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin improves metabolic syndrome induced by high fructose intake in rats.
    Kitagawa A; Ohta Y; Ohashi K
    J Pineal Res; 2012 May; 52(4):403-13. PubMed ID: 22220562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Melatonin as a regulator of metabolism].
    Dzherieva IS; Volkova NI; Rapoport SI
    Klin Med (Mosk); 2012; 90(10):27-30. PubMed ID: 23285758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin influences somatostatin secretion from human pancreatic δ-cells via MT1 and MT2 receptors.
    Zibolka J; Mühlbauer E; Peschke E
    J Pineal Res; 2015 Mar; 58(2):198-209. PubMed ID: 25585597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Melatonin. Physiology and clinical applications].
    Cardinali DP
    Vertex; 2007; 18(74):288-93. PubMed ID: 18219402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndrome.
    Robeva R; Kirilov G; Tomova A; Kumanov P
    Andrologia; 2006 Dec; 38(6):216-20. PubMed ID: 17081173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome.
    Koziróg M; Poliwczak AR; Duchnowicz P; Koter-Michalak M; Sikora J; Broncel M
    J Pineal Res; 2011 Apr; 50(3):261-6. PubMed ID: 21138476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin and glucose metabolism: clinical relevance.
    Lardone PJ; Alvarez-Sanchez SN; Guerrero JM; Carrillo-Vico A
    Curr Pharm Des; 2014; 20(30):4841-53. PubMed ID: 24251676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin normalizes clinical and biochemical parameters of mild inflammation in diet-induced metabolic syndrome in rats.
    Cano Barquilla P; Pagano ES; Jiménez-Ortega V; Fernández-Mateos P; Esquifino AI; Cardinali DP
    J Pineal Res; 2014 Oct; 57(3):280-90. PubMed ID: 25113124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome.
    Aguilera CM; Gil-Campos M; Cañete R; Gil A
    Clin Sci (Lond); 2008 Feb; 114(3):183-93. PubMed ID: 18184112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disorders and adipose tissue insulin responsiveness in neonatally STZ-induced diabetic rats are improved by long-term melatonin treatment.
    de Oliveira AC; Andreotti S; Farias Tda S; Torres-Leal FL; de Proença AR; Campaña AB; de Souza AH; Sertié RA; Carpinelli AR; Cipolla-Neto J; Lima FB
    Endocrinology; 2012 May; 153(5):2178-88. PubMed ID: 22374967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic disorders in elderly patients with hypertension and their correction with melatonin].
    Shatilo VB; Bondarenko EV; Antoniuk-Shcheglova IA
    Adv Gerontol; 2012; 25(1):84-9. PubMed ID: 22708450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and sleep in aging population.
    Pandi-Perumal SR; Zisapel N; Srinivasan V; Cardinali DP
    Exp Gerontol; 2005 Dec; 40(12):911-25. PubMed ID: 16183237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
    Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
    J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New evidence for a role of melatonin in glucose regulation.
    Peschke E; Mühlbauer E
    Best Pract Res Clin Endocrinol Metab; 2010 Oct; 24(5):829-41. PubMed ID: 21112029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.